Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Analyst: Monster Beverage Still No. 1, Sales Poised To Re-Accelerate

MNST

Credit Suisse reiterated its Outperform rating on Monster Beverage Corporation (NASDAQ: MNST), saying the company’s sales are set to re-accelerate in FY 2017.

Monster Beverage reported strong fourth quarter organic sales growth of nearly 15 percent with EPS of $0.30 that was in line with expectations.

Investors were cautious heading in to the print due to the slowing US energy category trends. But, the strong quarterly results should provide investors with some degree of comfort that the story remains in-tact.

Related Link: Zima Is Coming Back: Here Are 7 Other Retro Foods We Want To Try Again

The brokerage termed 2016 as a transition year in which the company terminated contracts with existing distributors and agree on commercial terms with the individual Coke bottlers around the world.

“Despite slower US category growth, we expect the company's organic sales to accelerate to 15 percent in FY17 from 13 percent last year driven by innovation in adjacent categories (Mutant, Hydro, and Caffe Monster), extension into the on-premise channel, and accelerated international expansion,” analyst Laurent Grandet wrote in a note.

Shares of Monster Beverage closed Wednesday’s trading at $42.01. In the pre-market hours Thursday, the stock climbed 13.90 percent to $47.85. Grandet has a price target of $59.

Latest Ratings for MNST

Date Firm Action From To
Dec 2016 Jefferies Upgrades Hold Buy
Sep 2016 Credit Suisse Initiates Coverage on Outperform
Aug 2016 Jefferies Maintains Hold

View More Analyst Ratings for MNST
View the Latest Analyst Ratings



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today